Estimates Revisions Abbott Laboratories Wiener Boerse
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Wiener Boerse
10/09/2026
|
5-day change | 1st Jan Change | ||
| 89.74 EUR | -1.92% |
|
-5.04% | -15.31% |
| 08/09 | Abbott Receives FDA Approval for Device to Treat Abnormal Heart Rhythm | DJ |
| 08/09 | Abbott Receives FDA Approval for TactiFlex Duo Ablation Catheter to Treat Abnormal Heart Rhythms | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Abbott Laboratories(ABT)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Abbott Laboratories(ABT)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Abbott Laboratories(ABT)
EBIT
Dividend / Share (DPS)
Data source:
Abbott Laboratories(ABT)
Cash or Net Debt
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
- Consensus Abbott Laboratories
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
